Sharing individual participant data from clinical trials: An opinion survey regarding the establishment of a central repository

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Smith, Catrin Tudur ^a   Dwan, Kerry ^a   Altman, Douglas G ^b   Clarke, Mike ^c   Riley, Richard ^d   Williamson, Paula R ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^d UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACCESS TO INFORMATION; ARTICLE; CLINICAL DATA REPOSITORY; CLINICAL RESEARCH; CLINICAL TRIAL (TOPIC); COMPUTER SECURITY; E-MAIL; HUMAN; INFORMATION PROCESSING; PATIENT INFORMATION; PROFESSIONAL KNOWLEDGE; QUESTIONNAIRE; STANDARDIZATION; WORKLOAD; FACTUAL DATABASE; INTERNET; PATIENT PARTICIPATION;

CLINICAL TRIALS AS TOPIC; DATA COLLECTION; DATABASES, FACTUAL; HUMANS; INTERNET; PATIENT PARTICIPATION; SURVEYS AND QUESTIONNAIRES;

EID: 84902214639     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0097886     Document Type: Article

References (44)

1. Vickers AJ (2006) Whose data set is it anyway? Sharing raw data from randomized trials. Trials 7: 15.
2. Gotzsche PC (2011) Why we need easy access to all data from all clinical trials and how to accomplish it. Trials 12: 249.
3. Walport M, Brest P (2001) Sharing research data to improve public health. Lancet 377: 537-539.
4. Chan A (2011) Access to clinical trial data: Results and protocols go hand in hand. BMJ 342: d80.
5. Godlee F, Groves T (2012) The new BMJ policy on sharing data from drug and device trials. BMJ 345: e7888.
6. The Cochrane Collaboration (2014) The Cochrane Collaboration Supports Free Access to all Data from all Clinical Trials. Available: http://www.cochrane.org/ organisational-policy-manual/27-access-data-all-trials: Accessed 8th May 2014.
7. Trials. About Trials: editorial policies, data and materials release. Available: http://www.trialsjournal.com/about#trials: Accessed 8th May 2014.
8. Nature publishing group. Authors and references, policies: availability of data and materials. Available: http://www.nature.com/authors/policies/ availability.html: Accessed 8th May 2014.
9. Chodacki J (2013) Improving Data Access at PLOS. Available: http://blogs.plos.org/biologue/2013/01/30/improving-data-access-at-plos/: Accessed 8th May 2014.
10. Dryad. Available: http://datadryad.org/: Accessed 8th May 2014.
11. All Trials Registered | All Results Reported. Available: http://www.alltrials.net/: Accessed 8th May 2014.
12. Eichler H-G, Abadie E, Breckenridge A, Leufkens H, Rasi G (2012) Open Clinical Trial Data for All? A View from Regulators. Plos Medicine 9: e1001202.
13. Medical Research Council. MRC policy on research data-sharing. Available: http://www.mrc.ac.uk/Ourresearch/Ethicsresearchguidance/datasharing/Policy/ index.htm: Accessed 8th May 2014.
14. National Institutes of Health. Final NIH statement on sharing research data. Available: http://grants.nih.gov/grants/guide/notice-files/NOT-OD-03-032. html: Accessed 8th May 2014.
15. Rathi V, Dzara K, Gross CP, Hrynaszkiewicz I, Joffe S, et al. (2012) Sharing of clinical trial data among trialists: a cross sectional survey. BMJ 345: e7570-e7570.
16. Savage CJ, Vickers AJ (2009) Empirical Study of Data Sharing by Authors Publishing in PLoS Journals. Plos One 4: e7078.
17. Kirwan J (1997) Making original data from clinical studies available for alternative analysis. Journal of Rheumatology 24: 822-825.
18. Sandercock P, Niewada M, Czlonkowska A, International Stroke Trial Collaborative Group (2011) The International Stroke Trial database. Trials 12: 101.
19. Bhattacharjee Y (2012) Pharma Firms Push for Sharing Of Cancer Trial Data. Science 338.
20. Defining Methodologies for Public Disclosure of Participant-level Data from Clinical Trials. Available: http://ottawagroup.ohri.ca/disclosure.html: Accessed 8th May 2014.
21. Riley RD, Lambert PC, Abo-Zaid G (2010) Meta-analysis of individual participant data: rationale, conduct, and reporting. BMJ 340: c221.
22. Ahmed I, Sutton AJ, Riley RD (2012) Assessment of publication bias, selection bias, and unavailable data in meta-analyses using individual participant data: a database survey. BMJ 344: d7762.
23. Tudur Smith C, Marson AG, Chadwick DW, Williamson PR (2007) Multiple treatment comparisons in epilepsy monotherapy trials. Trials 8: 34.
24. Donegan S, Williamson P, D'Alessandro U, Garner P, Tudur Smith C (2012) Combining individual patient data and aggregate data in mixed treatment comparison meta-analysis: Individual patient data may be beneficial if only for a subset of trials. Statistics in medicine 32: 914-930.
25. Donegan S, Williamson P, D'Alessandro U, Tudur Smith C (2012) Assessing the consistency assumption by exploring treatment by covariate interactions in mixed treatment comparison meta-analysis: individual patient-level covariates versus aggregate trial-level covariates. Statistics in medicine 31: 3840-3857.
26. Caldwell DM, Ades AE, Higgins JP (2005) Simultaneous comparison of multiple treatments: combining direct and indirect evidence. BMJ 331: 897-900. (Pubitemid 41502718)
27. Surveygizmo 3. Available: http://www.surveygizmo.com/: Accessed 8th May 2014.
28. Marson AG, Williamson PR, Hutton J, Clough HE, Chadwick DW (2000) Carbamazepine versus valproate monotherapy for epilepsy. Cochrane Db Syst Rev 3.
29. Muller M, Marson AG, Williamson PR (2006) Oxcarbazepine versus phenytoin monotherapy for epilepsy. Cochrane Db Syst Rev 2.
30. Taylor S, Tudur Smith C, Williamson PR, Marson AG (2003) Phenobarbitone versus phenytoin monotherapy for partial onset seizures and generalized onset tonic-clonic seizures. Cochrane Db Syst Rev.
31. Tudur Smith C, Marson AG, Williamson PR (2001) Phenytoin versus valproate monotherapy for partial onset seizures and generalized onset tonic-clonic seizures. Cochrane Db Syst Rev 10.1002/14651858.CD001769.
32. Tudur Smith C, Marson AG, Williamson PR (2003) Carbamazepine versus phenobarbitone monotherapy for epilepsy. Cochrane Db Syst Rev 10.1002/14651858.CD001904.
33. Tudur Smith C, Marson AG, Clough HE, Williamson PR (2002) Carbamazepine versus phenytoin monotherapy for epilepsy. Cochrane Db Syst Rev 10.1002/14651858.CD001911.
34. Marson AG, Al-Kharusi AM, Alwaidh M, Appleton R, Baker GA, et al. (2007) The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial. Lancet 369: 1000-1015. (Pubitemid 46436124)
35. Marson AG, Al-Kharusi AM, Alwaidh M, Appleton R, Baker GA, et al. (2007) The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. Lancet 369: 1016-1026. (Pubitemid 46436125)
36. NICE (2012) The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care. NICE clinical guideline CG137.
37. Williamson PR, Clough HE, Hutton JL, Marson AG, Chadwick DW (2002) Statistical issues in the assessment of the evidence for an interaction between factors in epilepsy trials. Statistics in medicine 21: 2613-2622.
38. Tudur Smith C, Williamson PR (2007) A comparison of methods for fixed effects meta-analysis of individual patient data with time to event outcomes. Clin Trials 4: 621-630.
39. Williamson P, Tudur Smith C, Sander J, Marson AG (2006) Competing risks of antiepileptic drug failure: Importance, measurement and analysis. Epilepsia 47: 12-12.
40. Williamson PR, Marson AG, Tudur C, Hutton JL, Chadwich D (2000) Individual patient data meta-analysis of randomized anti-epileptic drug monotherapy trials. J Eval Clin Pract 6: 205-214. (Pubitemid 30615011)
41. Williamson PR, Tudur Smith C, Hutton JL, Marson AG (2002) Aggregate data meta-analysis with time-to-event outcomes. Statistics in medicine 21: 3337-3351. (Pubitemid 35314654)
42. Tudur Smith C, Williamson PR, Marson AG (2005) Investigating heterogeneity in an individual patient data meta-analysis of time to event outcomes. Statistics in medicine 24: 1307-1319. (Pubitemid 40585170)
43. European Medicines Agency. Publication and access to clinical-trial data. Draft Policy. June 2013. EMA/240810/2013. Available: http://www.ema.europa.eu/ docs/en-GB/document-library/Other/2013/06/WC500144730.pdf Accessed 8th May 2014.
44. Sheehan KB (2001) E-mail Survey Response Rates: A Review. Journal of Computer-Mediated Communication 6: 0-0.